cm10 and cationic surfaces of q10 proteinchip arrays (Ciphergen inc)
Structured Review

Cm10 And Cationic Surfaces Of Q10 Proteinchip Arrays, supplied by Ciphergen inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proteinchip+array+cm10/wcx+2/pmc03494530-212-13-21
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass"
Article Title: A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass
Journal: Proteome Science
doi: 10.1186/1477-5956-10-45
Figure Legend Snippet: Classification results
Techniques Used:
Figure Legend Snippet: Pairwise comparisons between tumors of low malignant potential and hierarchical clustering of tissue data. Table with pairwise comparisons between mucinous and serous tumors of low malignant potential, cancer and benign tumor tissue. The number of upregulated (+) and downregulated (−) peaks is given for each comparison. Hierarchical clustering of CM10 tissue data. Clustering of 84 tissue samples using complete linkage and Pearson correlation distance on the 62 peaks that were differentially expressed (adjusted p-value < 0.05) between cancer, low malignant potential (divided in mucinous and serous), and benign tumor. The Z-score is calculated on the columns by subtracting the mean expression value of a column from each of the values and then dividing the resulting values by the standard deviation of the column. Color in the heat maps, therefore, indicates the relative expression level, with red being higher and blue lower than the mean expression value. The vertical side bar indicates the sample type: benign (red), mucinous LMP (green), serous LMP (purple), cancer (blue).
Techniques Used: Expressing, Standard Deviation
Figure Legend Snippet: Comparison of detected peaks in serum and tissue
Techniques Used:
Related Articles
Software:Article Title: Differential expression of proteomics models of colorectal cancer, colorectal benign disease and healthy controls Article Snippet: .. Experiments were performed using SELDI-TOF-MS instrument, other:Article Title: Detection and identification of NAP-2 as a biomarker in hepatitis B-related hepatocellular carcinoma by proteomic approach Article Snippet: Protein profiling of serum samples was performed using the Article Title: Interest of major serum protein removal for Surface-Enhanced Laser Desorption/Ionization – Time Of Flight (SELDI-TOF) proteomic blood profiling Article Snippet: Denaturated samples were then mixed with 100 μL of binding Article Title: Discovery and identification of potential biomarkers of papillary thyroid carcinoma Article Snippet: Biomarker Discovery:Article Title: Performance of a genetic algorithm for mass spectrometry proteomics Article Snippet: .. The low resolution dataset, DS1, was obtained from a ProteinChip Biomarker System-II (PBS-II) surface-enhanced laser desorption ionization time-of-flight (SELDI-TOF) instrument produced by Ciphergen Biosystems, Inc. of Fremont, CA, USA using a Article Title: Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, Platelet Factor-4 Article Snippet: Serum (20 μL) was fractionated by anion-exchange chromatography adopted from the Expression Difference Mapping (EDM) Serum Fractionation protocol (Ciphergen, Fremont, CA) in a 96-well format filter plate. .. Expression difference mapping (EDM) on Produced:Article Title: Performance of a genetic algorithm for mass spectrometry proteomics Article Snippet: .. The low resolution dataset, DS1, was obtained from a ProteinChip Biomarker System-II (PBS-II) surface-enhanced laser desorption ionization time-of-flight (SELDI-TOF) instrument produced by Ciphergen Biosystems, Inc. of Fremont, CA, USA using a Expressing:Article Title: Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, Platelet Factor-4 Article Snippet: Serum (20 μL) was fractionated by anion-exchange chromatography adopted from the Expression Difference Mapping (EDM) Serum Fractionation protocol (Ciphergen, Fremont, CA) in a 96-well format filter plate. .. Expression difference mapping (EDM) on |